TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
Study data from Oregon Health & Science University provide new insights into tuberculosis
October 14th, 2008
According to recent research from the United States, "End-stage renal disease (ESRD) patients are at high risk for tuberculosis (TB). IFN-gamma release assays that assess immune responses to specific TB antigens offer potential advantages over tuberculin skin testing (TST) in screening such patients for Mycobacterium tuberculosis infection." "This study sought to determine whether IFN-gamma release assay results are more closely associated with recent TB exposure than TST results. and measures: Prospective cohort investigation of patients at a hemodialysis center with a smear-positive case of TB. Patients without a history of TB underwent initial and repeat testing with...
Source: TB & Outbreaks Week (2008-10-14)
|
